 The investigators therefore designed a prospective randomized controlled trial comparing efficacy and safety of a low 900 IUday and high 1800IUday and 3300IUday maintenance dose of Cholecalciferol Vitamin D3 amongst community dwelling Indian and Malay with PMO living in Kuala Lumpur, Malaysia. 